- Sweden
- /
- Healthcare Services
- /
- OM:DEDI
Dedicare Second Quarter 2025 Earnings: EPS: kr0.95 (vs kr1.60 in 2Q 2024)
Dedicare (STO:DEDI) Second Quarter 2025 Results
Key Financial Results
- Revenue: kr355.1m (down 19% from 2Q 2024).
- Net income: kr9.10m (down 41% from 2Q 2024).
- Profit margin: 2.6% (down from 3.5% in 2Q 2024). The decrease in margin was driven by lower revenue.
- EPS: kr0.95 (down from kr1.60 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Dedicare's share price is broadly unchanged from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 3 warning signs for Dedicare you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:DEDI
Dedicare
Operates as a recruitment and staffing company in the healthcare, life science, education, and social work industries in Sweden, Norway, the United Kingdom, and Denmark.
Flawless balance sheet average dividend payer.
Market Insights
Weekly Picks

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Why Amdocs is a high conviction Buy for me?
Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend
Recently Updated Narratives
The Bloom Story is early days
Investor Thesis: Why the NextEra Energy / Dominion Energy Merger Could Be a Major AI Power Infrastructure Event

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era
Popular Narratives

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
A wonderful business at reasonable price.
Amazon's high growth, high tech segments propel its profits, while traditional segments plod along
Trending Discussion
Hey James! Thank you but I am not sure if I am reading this correctly as your analysis opens with "At A$36.602 per share, Woodside Energy Group (ASX: WDS) appears reasonably valued based on its existing operations and near-term production growth." I would like to say that the last time that WDS was above $36.00 per share was in October 2023, so I am a little confused by your statement w.r.t. current prices etc . Can you please explain?


